Literature DB >> 75545

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

P C Zamecnik, M L Stephenson.   

Abstract

The tridecamer d(A-A-T-G-G-T-A-A-A-A-T-G-G), which is complementary to 13 nucleotides of the 3'- and 5'-reiterated terminal sequences of Rous sarcoma virus 35S RNA, was added to chick embryo fibroblast tissue cultures infected with Rous sarcoma virus. Inhibition of virus production resulted. The inference emerges that the tridecamer and its counterpart with blocked 3'- and 5'-hydroxyl termini enter the chick fibroblast cells, hybridize with the terminal reiterated sequences at the 3' and 5' ends of the 35S RNA, and interfere with one or more steps involved in viral production and cell transformation. Likely sites of action are (i) the circularization step of the proviral DNA intermediate, and (ii) the initiation of translation, the latter being described in the following communication [Stephenson, M. L. & Zamecnik, P. C. (1978) Proc. Natl. Acad. Sci. USA 75, 285--288].

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75545      PMCID: PMC411230          DOI: 10.1073/pnas.75.1.280

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Plaque assay of avian sarcoma viruses using casein.

Authors:  P C Balduzzi; H Murphy
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

2.  The use of arylsulfonyltriazoles for the synthesis of oligonucleotides by the triester approach.

Authors:  N Katagiri; K Itakura; S A Narang
Journal:  J Am Chem Soc       Date:  1975-12-10       Impact factor: 15.419

3.  Analysis of oncornavirus RNA subunits by electron microscopy.

Authors:  U I Heine; G H Weber; M Cottler-Fox; M W Layard; M L Stephenson; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication.

Authors:  E Stoll; M A Billeter; A Palmenberg; C Weissmann
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

5.  Characterization of DNA complementary to nucleotide sequences adjacent to poly(A) at the 3'-terminus of the avian sarcoma virus genome.

Authors:  J Tal; H J Kung; H E Varmus; J M Bishop
Journal:  Virology       Date:  1977-06-01       Impact factor: 3.616

6.  Characterization of DNA complementary to nucleotide sequences at the 5'-terminus of the avian sarcoma virus genome.

Authors:  R Friedrich; H J Kung; B Baker; H E Varmus; H M Goodman; J M Bishop
Journal:  Virology       Date:  1977-06-01       Impact factor: 3.616

7.  The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

8.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

9.  Effects of polyadenylic acids on functions of murine RNA tumor viruses.

Authors:  R W Tennant; J G Farrelly; J N Ihle; B C Pal; F T Kenney; A Brown
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

10.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

View more
  336 in total

Review 1.  Gene therapy for brain tumors.

Authors:  K Bansal; H H Engelhard
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Antisense cancer therapy: the state of the science.

Authors:  D M Kushner; R H Silverman
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

3.  Hybrid characteristics of oligonucleotides consisting of isonucleoside 2',5'-anhydro-3'-deoxy-3'-(thymin-1-yl)-D-mannitol with different linkage modes.

Authors:  Z Lei; L Zhang; L R Zhang; J Chen; J M Min; L H Zhang
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

4.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  -CH2- lengthening of the internucleotide linkage in the ApA dimer can improve its conformational compatibility with its natural polynucleotide counterpart.

Authors:  J Hanus; I Barvík; K Ruszová-Chmelová; J Stepánek; P Y Turpin; J Bok; I Rosenberg; M Petrová-Endová
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

6.  Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.

Authors:  Philippe de Diesbach; Francisca N'Kuli; Catherine Berens; Etienne Sonveaux; Michel Monsigny; Annie-Claude Roche; Pierre J Courtoy
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

7.  2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies.

Authors:  C J Wilds; M J Damha
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

Review 8.  Preclinical and clinical pharmacology of antisense oligonucleotides.

Authors:  E G Marcusson; B R Yacyshyn; W R Shanahan; N M Dean
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

9.  Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor.

Authors:  Maja Hemmings-Mieszczak; Gabriele Dorn; François J Natt; Jonathan Hall; William L Wishart
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

10.  Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.

Authors:  M Kulka; C C Smith; L Aurelian; R Fishelevich; K Meade; P Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.